본문 바로가기 주메뉴 바로가기

Conferences

Conference Information

2024 Annual Meeting and International Conference of the KSPST

November 26th(Tue) - 28th(Thu), 2024

The-K Hotel Seoul, Seoul, Republic of Korea

Sponsors
  • Prestige Sponsor
    • 한미약품
  • Diamond Sponsor
    • 대웅제약
  • Platinum Sponsor
    • (주)바이오인프라
    • 한국유나이티드제약
    • 동국제약
    • 지엘팜텍
  • Gold Sponsor
    •  SK바이오사이언스
    • 하나제약(주)
    •  환인제약
    •  녹십자
    •  렉스팜텍
    •  씨티씨바이오
    •  에스엔바이오사이언스
    •  인벤티지랩
    •  셀메드
    •  종근당
    •  한림제약
    •  삼진제약
    •  JW생명과학
    •  휴온스
    •  삼양홀딩스
    •  동아ST
    •  대원제약

Featured Speakers


Plenary Speaker

Prof. Twan Lammers

RWTH Aachen University, Germany President of Controlled Release Society

Strategies to promote cancer nanomedicine clinical translation



  • Prof. Paolo Caliceti

    University of Padua, Italy Associate Editor of J Control Release

    Tailored supramolecular architectures for biological drug delivery



  • Prof. Yoon Yeo

    Purdue University, USA Deputy Editors-in-Chief of J Control Release

    Leveraging cancer immunotherapy by spatiotemporal control of drug delivery



  • Prof. Xun Sun

    Sichuan University, China Associate Editor of J Control Release

    Drug delivery systems for immunomodulation and gene therapy



  • Prof. Maria A. Croyle

    The University of Texas at Austin, USA

    Platform technologies for personalized health



  • Prof. Yoshiyuki Shirasaka

    Kanazawa University, Japan

    Quantitative analysis of gastrointestinal drug absorption and disposition using cutting-edge technology



  • Prof. Jurgen Bulitta

    University of Florida, USA

    Combating multidrug-resistant bacterial superbugs by learning how to play the penicillin-binding protein receptor piano



  • Prof. Cong Luo

    Shenyang Pharmaceutical University, China

    Carrier-free small-molecule nanoassemblies for biomedical applications



  • Prof. Qikun Jiang

    Shenyang Pharmaceutical University, China

    Research on intestinal transporter mediated innovative drugs



  • Dr. Jong Bong Lee

    Novartis, USA

    Radioligand therapy: For a wider therapeutic index than antibody-drug conjugates



  • Shantanu Damle

    Colorcon Asia, India

    Achieving zero-order extended drug release from lab to commercial scale



  • Dr. Ryo Kojima

    Astellas Pharma, Japan

    Development and manufacturing of mRNA-LNP therapeutics from industry perspective




  • Prof. Hsing-Wen Sung

    National Tsing Hua University, Taiwan

    Noninvasive gut-to-brain oral delivery systems




  • Prof. Fakhar-ud-Din

    Quaid-i-Azam University, Pakistan

    Nanomedicine-based strategies for targeting tumor microenvironment: Opportunities & challenges




  • Prof. Jiong-Wei Wang

    National University of Singapore, Singapore

    Nanomedicines targeting plaque inflammation in atherosclerosis